Regeneron Study Site
Minneapolis, Minnesota
We've found
3 trials
at this facility
Dermatitis, Atopic Clinical Trial
Updated: 12/31/1969
Safety, Pharmacokinetics and Efficacy of Dupilumab in Patients ≥6 Months to
Status: Enrolling,
Phase
II, III
Updated: 12/31/1969
Click here to add this to my saved trials
Peanut Allergy Clinical Trial
Updated: 12/31/1969
Study in Pediatric Subjects With Peanut Allergy to Evaluate the Efficacy and Safety of Dupilumab as Adjunct to AR101 (Peanut Oral Immunotherapy)
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Atopic Dermatitis Clinical Trial
Updated: 1/4/2016
Open Label, Drug-Drug Interaction (DDI) Study of Dupilumab (REGN668/SAR231893) in Patients With Moderate to Severe Atopic Dermatitis (AD)
Status: Enrolling,
Phase
I
Updated: 1/4/2016
Click here to add this to my saved trials